AREC — Arecor Therapeutics Share News
0.000.00%
Last trade - 00:00
- £39.36m
- £31.29m
- £2.40m
REG - Arecor Therapeutics - Headline results from Phase I trial of AT247
AnnouncementRCS - Arecor Therapeutics - Arecor Presents Positive Data for AT278 at EASD
AnnouncementREG - Arecor Therapeutics - Interim Results for six months ended 30 June 2022
AnnouncementREG - Arecor Therapeutics - Notice of Interim Results
AnnouncementREG - Arecor Therapeutics - ARECOR GRANTED EUROPEAN PATENTS
AnnouncementREG - Arecor Therapeutics - Holding(s) in Company
AnnouncementREG - Arecor Therapeutics - Holding(s) in Company
AnnouncementREG - Arecor Therapeutics - Holding(s) in Company
AnnouncementREG - Arecor Therapeutics - Holding(s) in Company
AnnouncementREG - Arecor Therapeutics - Holding(s) in Company
AnnouncementREG - AIM - AIM Notice - 04/08/2022
AnnouncementREG - Arecor Therapeutics - Director/PDMR Dealings
AnnouncementRCS - Arecor Therapeutics - Arecor on Investor Meet Company Platform
AnnouncementREG - Arecor Therapeutics - Result of Placing
AnnouncementREG - Arecor Therapeutics - Proposed Acquisition of Tetris Pharma Ltd
AnnouncementREG - Arecor Therapeutics - BUSINESS UPDATE
AnnouncementRCS - Arecor Therapeutics - ARECOR ANNOUNCES PRESENTATION AT EASD 2022
AnnouncementREG - Arecor Therapeutics - ARECOR COLLABORATES WITH TOP GLOBAL PHARMA COMPANY
AnnouncementREG - Arecor Therapeutics - RESULT OF AGM
Announcement